Evaxion Biotech AS (EVAX) is a clinical-stage biopharmaceutical company headquartered in Hørsholm, Denmark, specializing in the development of innovative immunotherapies through its cutting-edge artificial intelligence and immunology platform. The company is focused on addressing significant unmet medical needs in oncology, bacterial diseases, and viral infections by harnessing its proprietary technology to identify and design novel therapeutic candidates. As it advances its pipeline, Evaxion aims to revolutionize the treatment landscape and improve patient outcomes, positioning itself as a key player in the biotechnology sector.